Hikma Pharmaceutical | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
Almirall EUR -50222000 162.22M 2024-06
argenx SE USD 285.94M 8.24M 2024-12
AstraZeneca USD 5.55B 307M 2024-12
Autolus Therapeutics Ltd 27.33M 5.43M 2024-09
Bayer EUR 4.34B 610M 2024-12
Fresenius EUR 769M 68M 2024-12
Galapagos EUR 41.25M 11.98M 2024-12
Genmab DKK 1.25B 384M 2024-12
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
GRIFOLS EUR 269.48M 49.95M 2024-12
Hikma Pharmaceutical USD 280M 4M 2024-06
Merck EUR 1.41B 72M 2024-09
Orion EUR 114.9M 29.1M 2024-12
Recordati EUR 149.34M 15.49M 2024-09
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.68B 26M 2024-09
UCB EUR 533M 434M 2024-06



Hikma Pharmaceutical Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Mar 2025.